Report : A-Z HCD items in Formulary 23/09/2018 07:42:23

[Back]

Section Status BlueTeq Name 08.03.04.02 Formulary Abiraterone tabs  11.99.99.99 Formulary Adalimumab injection uveitis 13.05.03 Formulary Adalimumab injection Hidradenitis suppurativa 08.02.03 Formulary Alemtuzumab injection multiple sclerosis 10.01.04 Formulary Anakinra injection Adult-Onset Still's Disease 05.01.09 Formulary Bedaquiline tabs Sirturo® 10.01.03 Restricted Use Belimumab injection  08.01.01 Formulary Bendamustine injection  08.02.03 Formulary Blinatumomab injection  08.01.05 Formulary Bosutinib tabs  08.01.05 Formulary Brentuximab injection  03.04.03 Formulary C1 esterase inhibitor injection  08.01.05 Formulary Cabazitaxel injection  08.01.05 Formulary Cabozantinib tablets Cabometyx 08.01.05 Formulary Carfilzomib injection   08.01.05 Formulary Ceritinib caps  08.01.05 Formulary Cetuximab injection colorectal cancer 08.01.05 Formulary Cetuximab injection head and neck cancer 08.02.04 Formulary Cladribine tabs multiple sclerosis 04.09.01 Formulary Co-careldopa intestinal gel Duodopa® 08.01.05 Formulary Crizotinib caps  05.03.03.02 Formulary Daclatasvir tabs  05.03.03.02 Formulary Dasabuvir tabs  08.01.05 Formulary Dasatinib tabs  02.08.01 Formulary Defibrotide infusion  05.01.09 Formulary Delamanid tabs Deltyba® 08.02.04 Formulary Dimethyl fumarate caps Tecfidera - multiple sclerosis 09.01.03 Formulary Eculizumab injection Atypical Haemolytic Uraemic Syndrome [aHUS] 09.01.03 Restricted Use Eculizumab injection C3 glomerulopathy post-kidney transplant 05.03.03.02 Formulary Epclusa® tabs sofosbuvir and velpatasvir 08.01.05 Formulary Eribulin injection  09.05.01.02 Formulary Etelcalcetide injection  08.01.05 Formulary Everolimus tabs neuroendocrine tumours 08.01.05 Formulary Everolimus tabs breast cancer and renal cancer 08.02.04 Formulary Fingolimod caps  08.02.04 Formulary Glatiramer acetate injection  05.03.03.02 Formulary Harvoni® tabs sofosbuvir and ledipasvir 08.01.05 Formulary Ibrutinib caps  08.02.04 Formulary Interferon beta-1a injection  08.02.04 Formulary Interferon beta-1b injection  03.07 Formulary Mannitol inhalation powder Bronchitol® 05.03.03.02 Formulary Maviret® tabs glecaprevir and pibrentasvir 03.04.02 Formulary Mepolizumab injection  08.02.04 Restricted Use Natalizumab injection  08.01.05 Formulary Nilotinib caps  03.11 Formulary Nintedanib caps Ofev® - idiopathic pulmonary fibrosis 08.01.05 Formulary Nivolumab injection GSTFT and KCH 01.09.01 Formulary Obeticholic acid tabs  08.02.04 Formulary Ocrelizumab injection  03.04.02 Restricted Use Omalizumab injection asthma 08.01.05 Formulary Paclitaxel albumin injection Abraxane 08.01.05 Formulary Panitumumab injection  08.03.04.03 Formulary Pasireotide injection  08.02.04 Formulary Peginterferon beta-1a injection  06.05.01 Formulary Pegvisomant injection  08.01.05 Formulary Pembrolizumab injection lung cancer indications 08.01.03 Formulary Pemetrexed injection  08.01.05 Formulary Pertuzumab injection  03.11 Formulary Pirfenidone caps  09.01.07 Restricted Use Plerixafor injection  08.02.04 Formulary Pomalidomide caps  08.01.05 Formulary Ponatinib tabs  03.04.02 Formulary Reslizumab injection  10.01.03 Restricted Use Rituximab injection rheumatology - off-label indications 10.01.03 Formulary Rituximab injection ANCA vasculitis 05.03.03.02 Formulary Simeprevir caps  05.03.03.02 Formulary Sofosbuvir tabs  08.01.05 Formulary Sorafenib tablets Hepatocellular carcinoma 08.01.05 Formulary Sunitinib caps neuroendocrine tumours 08.02.04 Formulary Teriflunomide tablets  10.01.03 Formulary Tocilizumab injection Adult-Onset Still's Disease 08.01.05 Formulary Trametinib tabs  08.01.05 Formulary Trastuzumab emtansine injection   08.01.03 Formulary Trifluridine–tipiracil tablets  05.03.03.02 Formulary Viekirax® ombitasvir with paritaprevir and ritonavir 05.03.03.02 Formulary Vosevi® tabs sofosbuvir, velpatasvir and voxilaprevir 05.03.03.02 Formulary Zepatier® tabs elbasvir and grazoprevir

South East London Joint Medicines Formulary